Diet-induced obesity model

From WikiMD's WELLNESSPEDIA

Diet-induced obesity model is a widely used experimental model in biomedical research that mimics the human condition of obesity and its associated metabolic disorders. This model is created by feeding animals, usually rodents, a high-fat diet (HFD) that is rich in saturated fats and sugars.

Overview[edit]

The Diet-induced obesity model is a research tool used to study the physiological and molecular mechanisms underlying obesity and its related metabolic disorders such as type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease. The model is created by feeding animals, usually rodents, a high-fat diet (HFD) that is rich in saturated fats and sugars. The HFD induces obesity and metabolic disorders in the animals, which can then be studied to understand the pathogenesis of these conditions in humans.

Mechanism[edit]

The mechanism of diet-induced obesity involves the overconsumption of energy-dense foods, leading to an energy imbalance and excess fat accumulation. The HFD induces insulin resistance, a key feature of metabolic syndrome, by increasing the levels of free fatty acids and inflammatory cytokines in the body. These factors interfere with insulin signaling, leading to impaired glucose uptake and hyperglycemia.

Applications[edit]

The diet-induced obesity model is used in various areas of biomedical research. It is used to study the pathogenesis of obesity and its related metabolic disorders, to test the efficacy of anti-obesity drugs, and to investigate the effects of dietary interventions on obesity and metabolic health.

Limitations[edit]

While the diet-induced obesity model is a valuable tool in obesity research, it has some limitations. Not all animals fed a HFD develop obesity and metabolic disorders, reflecting the genetic and environmental factors that contribute to these conditions in humans. Furthermore, the model does not fully replicate the complex etiology of human obesity, which involves not only diet but also factors such as physical activity, sleep, and stress.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.